Advanced Kidney Cancer - Median Progression-free Survival Doubled For Patients Treated With Nexavar (sorafenib), Phase III Data

Mon, 15 Jan 2007 09:00 AM EST

... Bayer HealthCare today announced the publication of encouraging Phase III data on sorafenib tablets - a treatment for patients with advanced renal cell carcinoma (RCC/kidney cancer), in the New England Journal of Medicine (NEJM). [click link for full article] ...